which normally mediate penetration of inflammatory cells through the blood-brain barrier into CNS tissue. Several studies have also indicated that IFN-β promotes immune modulation, although the ...

In addition to its clinical programs, Reviva is developing a range of preclinical programs focused on indications in which neurotransmitter modulation ... a class of CNS therapeutics with a ...

The purpose of this joint agreement is to conduct pre-clinical studies for the development of a new gene therapy for the undisclosed CNS disease by applying J-Brain Cargo, JCR’s proprietary technology ...

The purpose of this joint agreement is to conduct pre-clinical studies for the development of a new gene therapy for the undisclosed CNS disease by applying J-Brain Cargo ®, JCR’s proprietary ...